ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (Ischemic cardiomyopathy already excluded)

Leena Mammen, Pamela K. Woodard, Suhny Abbara, Sharmila Dorbala, Cylen Javidan-Nejad, Paul R. Julsrud, Jacobo Kirsch, Christopher M. Kramer, Rajesh Krishnamurthy, Archana T. Laroia, Amar B. Shah, Jens Vogel-Claussen, Richard D. White

Research output: Contribution to journalArticle

Abstract

Nonischemic myocardial disease or cardiomyopathy can present as arrhythmia, palpitations, heart failure, dyspnea, lower extremity edema, ascites, syncope, and/or chest discomfort and can be classified as either systolic, diastolic, or a combination of both. Echocardiography is the mainstay of evaluating left ventricular function. However, cardiac magnetic resonance imaging (MRI) is now considered the reference standard imaging technique to assess myocardial anatomy, function, and viability. Advanced MRI techniques with delayed myocardial enhancement, especially, can provide information beyond echocardiography for tissue characterization in CM and can assist in determining specific etiology or in narrowing the differential. Often imaging enhancement patterns, signal characteristics, and morphology on MRI can lead to specific diagnoses such as amyloidosis, hypertrophic CM, or iron deposition. Cardiac computed tomography is usually used in excluding coronary artery disease but can also be used in some patients unable to undergo cardiac MRI to assess arrhythmogenic right ventricular dysplasia. Both 18-F-fluoro-2-deoxyglucose positron emission tomography and delayed contrast-enhanced MRI can be used to assess for cardiac sarcoidosis. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Original languageEnglish (US)
JournalJournal of Thoracic Imaging
Volume29
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Cardiomyopathies
Magnetic Resonance Imaging
Echocardiography
Guidelines
Arrhythmogenic Right Ventricular Dysplasia
Deoxyglucose
Expert Testimony
Syncope
Amyloidosis
Sarcoidosis
Left Ventricular Function
Ascites
Radiology
Positron-Emission Tomography
Dyspnea
Cardiac Arrhythmias
Coronary Artery Disease
Lower Extremity
Edema
Anatomy

Keywords

  • Appropriateness Criteria
  • Nonischemic cardiomyopathy
  • Nonischemic heart failure
  • Nonischemic myocardial disease

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (Ischemic cardiomyopathy already excluded). / Mammen, Leena; Woodard, Pamela K.; Abbara, Suhny; Dorbala, Sharmila; Javidan-Nejad, Cylen; Julsrud, Paul R.; Kirsch, Jacobo; Kramer, Christopher M.; Krishnamurthy, Rajesh; Laroia, Archana T.; Shah, Amar B.; Vogel-Claussen, Jens; White, Richard D.

In: Journal of Thoracic Imaging, Vol. 29, No. 4, 2014.

Research output: Contribution to journalArticle

Mammen, L, Woodard, PK, Abbara, S, Dorbala, S, Javidan-Nejad, C, Julsrud, PR, Kirsch, J, Kramer, CM, Krishnamurthy, R, Laroia, AT, Shah, AB, Vogel-Claussen, J & White, RD 2014, 'ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (Ischemic cardiomyopathy already excluded)', Journal of Thoracic Imaging, vol. 29, no. 4. https://doi.org/10.1097/RTI.0000000000000096
Mammen, Leena ; Woodard, Pamela K. ; Abbara, Suhny ; Dorbala, Sharmila ; Javidan-Nejad, Cylen ; Julsrud, Paul R. ; Kirsch, Jacobo ; Kramer, Christopher M. ; Krishnamurthy, Rajesh ; Laroia, Archana T. ; Shah, Amar B. ; Vogel-Claussen, Jens ; White, Richard D. / ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (Ischemic cardiomyopathy already excluded). In: Journal of Thoracic Imaging. 2014 ; Vol. 29, No. 4.
@article{17edb323cbd94345baf8040695c74ea9,
title = "ACR appropriateness criteria{\circledR} nonischemic myocardial disease with clinical manifestations (Ischemic cardiomyopathy already excluded)",
abstract = "Nonischemic myocardial disease or cardiomyopathy can present as arrhythmia, palpitations, heart failure, dyspnea, lower extremity edema, ascites, syncope, and/or chest discomfort and can be classified as either systolic, diastolic, or a combination of both. Echocardiography is the mainstay of evaluating left ventricular function. However, cardiac magnetic resonance imaging (MRI) is now considered the reference standard imaging technique to assess myocardial anatomy, function, and viability. Advanced MRI techniques with delayed myocardial enhancement, especially, can provide information beyond echocardiography for tissue characterization in CM and can assist in determining specific etiology or in narrowing the differential. Often imaging enhancement patterns, signal characteristics, and morphology on MRI can lead to specific diagnoses such as amyloidosis, hypertrophic CM, or iron deposition. Cardiac computed tomography is usually used in excluding coronary artery disease but can also be used in some patients unable to undergo cardiac MRI to assess arrhythmogenic right ventricular dysplasia. Both 18-F-fluoro-2-deoxyglucose positron emission tomography and delayed contrast-enhanced MRI can be used to assess for cardiac sarcoidosis. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.",
keywords = "Appropriateness Criteria, Nonischemic cardiomyopathy, Nonischemic heart failure, Nonischemic myocardial disease",
author = "Leena Mammen and Woodard, {Pamela K.} and Suhny Abbara and Sharmila Dorbala and Cylen Javidan-Nejad and Julsrud, {Paul R.} and Jacobo Kirsch and Kramer, {Christopher M.} and Rajesh Krishnamurthy and Laroia, {Archana T.} and Shah, {Amar B.} and Jens Vogel-Claussen and White, {Richard D.}",
year = "2014",
doi = "10.1097/RTI.0000000000000096",
language = "English (US)",
volume = "29",
journal = "Journal of Thoracic Imaging",
issn = "0883-5993",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - ACR appropriateness criteria® nonischemic myocardial disease with clinical manifestations (Ischemic cardiomyopathy already excluded)

AU - Mammen, Leena

AU - Woodard, Pamela K.

AU - Abbara, Suhny

AU - Dorbala, Sharmila

AU - Javidan-Nejad, Cylen

AU - Julsrud, Paul R.

AU - Kirsch, Jacobo

AU - Kramer, Christopher M.

AU - Krishnamurthy, Rajesh

AU - Laroia, Archana T.

AU - Shah, Amar B.

AU - Vogel-Claussen, Jens

AU - White, Richard D.

PY - 2014

Y1 - 2014

N2 - Nonischemic myocardial disease or cardiomyopathy can present as arrhythmia, palpitations, heart failure, dyspnea, lower extremity edema, ascites, syncope, and/or chest discomfort and can be classified as either systolic, diastolic, or a combination of both. Echocardiography is the mainstay of evaluating left ventricular function. However, cardiac magnetic resonance imaging (MRI) is now considered the reference standard imaging technique to assess myocardial anatomy, function, and viability. Advanced MRI techniques with delayed myocardial enhancement, especially, can provide information beyond echocardiography for tissue characterization in CM and can assist in determining specific etiology or in narrowing the differential. Often imaging enhancement patterns, signal characteristics, and morphology on MRI can lead to specific diagnoses such as amyloidosis, hypertrophic CM, or iron deposition. Cardiac computed tomography is usually used in excluding coronary artery disease but can also be used in some patients unable to undergo cardiac MRI to assess arrhythmogenic right ventricular dysplasia. Both 18-F-fluoro-2-deoxyglucose positron emission tomography and delayed contrast-enhanced MRI can be used to assess for cardiac sarcoidosis. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

AB - Nonischemic myocardial disease or cardiomyopathy can present as arrhythmia, palpitations, heart failure, dyspnea, lower extremity edema, ascites, syncope, and/or chest discomfort and can be classified as either systolic, diastolic, or a combination of both. Echocardiography is the mainstay of evaluating left ventricular function. However, cardiac magnetic resonance imaging (MRI) is now considered the reference standard imaging technique to assess myocardial anatomy, function, and viability. Advanced MRI techniques with delayed myocardial enhancement, especially, can provide information beyond echocardiography for tissue characterization in CM and can assist in determining specific etiology or in narrowing the differential. Often imaging enhancement patterns, signal characteristics, and morphology on MRI can lead to specific diagnoses such as amyloidosis, hypertrophic CM, or iron deposition. Cardiac computed tomography is usually used in excluding coronary artery disease but can also be used in some patients unable to undergo cardiac MRI to assess arrhythmogenic right ventricular dysplasia. Both 18-F-fluoro-2-deoxyglucose positron emission tomography and delayed contrast-enhanced MRI can be used to assess for cardiac sarcoidosis. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

KW - Appropriateness Criteria

KW - Nonischemic cardiomyopathy

KW - Nonischemic heart failure

KW - Nonischemic myocardial disease

UR - http://www.scopus.com/inward/record.url?scp=84903767856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903767856&partnerID=8YFLogxK

U2 - 10.1097/RTI.0000000000000096

DO - 10.1097/RTI.0000000000000096

M3 - Article

C2 - 24905633

AN - SCOPUS:84903767856

VL - 29

JO - Journal of Thoracic Imaging

JF - Journal of Thoracic Imaging

SN - 0883-5993

IS - 4

ER -